These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16757360)

  • 1. Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer.
    Rosen DG; Yang G; Bast RC; Liu J
    Methods Enzymol; 2006; 407():660-76. PubMed ID: 16757360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
    Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
    Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.
    Nitta M; Katabuchi H; Ohtake H; Tashiro H; Yamaizumi M; Okamura H
    Gynecol Oncol; 2001 Apr; 81(1):10-7. PubMed ID: 11277643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
    Wang B; Soule HD; Miller FR
    Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis.
    Okamura H; Katabuchi H
    Int Rev Cytol; 2005; 242():1-54. PubMed ID: 15598466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer.
    Yang G; Thompson JA; Fang B; Liu J
    Oncogene; 2003 Aug; 22(36):5694-701. PubMed ID: 12944918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.
    Alvero AB; Fishman DA; Qumsiyeh MB; Garg M; Kacinski BM; Sapi E
    J Soc Gynecol Investig; 2004 Dec; 11(8):553-61. PubMed ID: 15582501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology.
    Okamura H; Katabuchi H; Nitta M; Ohtake H
    Microsc Res Tech; 2006 Jun; 69(6):469-81. PubMed ID: 16718660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic transformation of human epithelial cells in vitro.
    Rhim JS
    Anticancer Res; 1989; 9(5):1345-65. PubMed ID: 2686534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
    Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
    Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
    Mei FC; Young TW; Liu J; Cheng X
    FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression.
    Miyanishi M; Mandai M; Matsumura N; Yamaguchi K; Hamanishi J; Higuchi T; Takakura K; Fujii S
    Oncol Rep; 2007 Feb; 17(2):329-33. PubMed ID: 17203169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.
    O'Hayer KM; Counter CM
    Methods Enzymol; 2006; 407():637-47. PubMed ID: 16757358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
    Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.